Literature DB >> 14613676

Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity.

Georg Juckel1, Jürgen Gallinat, Michael Riedel, Safet Sokullu, Carl Schulz, Hans-Jürgen Möller, Norbert Müller, Ulrich Hegerl.   

Abstract

Increased serotonergic activity is discussed as an important pathogenetic factor in schizophrenia. Further support for this hypothesis is difficult to obtain due to the lack of valid indicators of the brain's serotonin system. A great deal of evidence discovered through human and animal studies suggests that a weak loudness dependence of auditory evoked potentials (LDAEP) indicates high serotonergic activity and vice versa. The LDAEP is a measure of auditory cortex activity, reflecting increase or decrease of auditory evoked potential amplitudes with increasing tone loudness, which is probably modulated by the serotonergic innervation there. This is true only for the LDAEP of the primary auditory cortex, since this region is more highly innervated by serotonergic fibers than the secondary auditory cortex. The LDAEP (N1/P2 component) of 25 inpatients with schizophrenia free of medication and 25 healthy controls matched by age and gender, were recorded. Using dipole source analysis, the LDAEP of primary (tangential dipole) and this of secondary auditory cortex (radial dipole) was separately analyzed. Following a 4-week treatment with the 5-HT(2) antagonists clozapine or olanzapine, patients were once again studied. The LDAEP of the primary, but not of the secondary auditory cortex, was significantly weaker in the patients with schizophrenia than in healthy volunteers, indicating enhanced serotonergic neurotransmission. After treatment with the 5-HT(2) antagonists, the LDAEP (of the right hemisphere) tended to be increased, indicating normalization of serotonergic function in the patients with schizophrenia. These results suggest that the loudness dependence of primary auditory cortex evoked activity is well suitable to assess serotonergic dysfunction in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14613676     DOI: 10.1016/s0920-9964(03)00016-1

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  22 in total

1.  Relationship between SSRI-induced sexual dysfunction and central serotonergic activity based on the loudness dependence of auditory evoked potentials.

Authors:  Young-Min Park
Journal:  Psychopharmacology (Berl)       Date:  2013-09-05       Impact factor: 4.530

2.  Neurophysiological investigation of auditory intensity dependence in patients with Parkinson's disease.

Authors:  Kim De Keyser; Miet De Letter; Patrick Santens; Durk Talsma; Dick Botteldooren; Annelies Bockstael
Journal:  J Neural Transm (Vienna)       Date:  2021-01-30       Impact factor: 3.575

3.  Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans.

Authors:  Barry V O'Neill; Rodney J Croft; Sumie Leung; Valérie Guille; Matthew Galloway; K Luan Phan; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

4.  The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder.

Authors:  Young-Min Park; Do-Won Kim; Sangrae Kim; Chang-Hwan Im; Seung-Hwan Lee
Journal:  Psychopharmacology (Berl)       Date:  2010-11-06       Impact factor: 4.530

5.  Loudness- and time-dependence of auditory evoked potentials is blunted by the NMDA channel blocker MK-801.

Authors:  Tobias Teichert
Journal:  Psychiatry Res       Date:  2017-06-15       Impact factor: 3.222

6.  Somatosensory system deficits in schizophrenia revealed by MEG during a median-nerve oddball task.

Authors:  Ming-Xiong Huang; Roland R Lee; Kathleen M Gaa; Tao Song; Deborah L Harrington; Cathy Loh; Rebecca J Theilmann; J Christopher Edgar; Gregory A Miller; Jose M Canive; Eric Granholm
Journal:  Brain Topogr       Date:  2009-11-27       Impact factor: 3.020

7.  Dopamine and serotonin levels following prenatal viral infection in mouse--implications for psychiatric disorders such as schizophrenia and autism.

Authors:  Christine Winter; Teri J Reutiman; Timothy D Folsom; Reinhard Sohr; Rainer J Wolf; Georg Juckel; S Hossein Fatemi
Journal:  Eur Neuropsychopharmacol       Date:  2008-08-06       Impact factor: 4.600

8.  High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans.

Authors:  Barry V O'Neill; Rodney J Croft; Sumie Leung; Chris Oliver; K Luan Phan; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2007-07-24       Impact factor: 4.530

9.  The ZInEP Epidemiology Survey: background, design and methods.

Authors:  Vladeta Ajdacic-Gross; Mario Müller; Stephanie Rodgers; Inge Warnke; Michael P Hengartner; Karin Landolt; Florence Hagenmuller; Magali Meier; Lee-Ting Tse; Aleksandra Aleksandrowicz; Marco Passardi; Daniel Knöpfli; Herdis Schönfelder; Jochen Eisele; Nicolas Rüsch; Helene Haker; Wolfram Kawohl; Wulf Rössler
Journal:  Int J Methods Psychiatr Res       Date:  2014-06-18       Impact factor: 4.035

10.  Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.

Authors:  Karsten Heekeren; Jörg Daumann; Anna Neukirch; Carsten Stock; Wolfram Kawohl; Christine Norra; Till D Waberski; Euphrosyne Gouzoulis-Mayfrank
Journal:  Psychopharmacology (Berl)       Date:  2008-05-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.